e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Sarcoidosis, interstitial lung diseases and various clinical problems
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cavitary nodules in rheumatoid arthritis patients and their prognosis
D. Kocakaya (Istanbul, Turkey), A. Aksoy (Istanbul, Turkey), Y. Yalçinkaya (Istanbul, Turkey), N. Inanç (Istanbul, Turkey), E. Eryüksel (Istanbul, Turkey), S. Karakurt (Istanbul, Turkey)
Source:
International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Session:
Sarcoidosis, interstitial lung diseases and various clinical problems
Session type:
Thematic Poster
Number:
4116
Disease area:
Interstitial lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Kocakaya (Istanbul, Turkey), A. Aksoy (Istanbul, Turkey), Y. Yalçinkaya (Istanbul, Turkey), N. Inanç (Istanbul, Turkey), E. Eryüksel (Istanbul, Turkey), S. Karakurt (Istanbul, Turkey). Cavitary nodules in rheumatoid arthritis patients and their prognosis. 4116
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Pulmonary nodular lesions in rheumatoid arthritis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 60s
Year: 2002
Pulmonary involvement in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 381s
Year: 2006
Pulmonary manifestations in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 100s
Year: 2006
Interstitial lung disease in patients with rheumatoid arthritis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008
Massive cavitary pulmonary rheumatoid nodules in a patient with HIV
Source: Eur Respir J 2006 Oct 01;28(4):872-874
Year: 2006
Mortality and clinical features in rheumatoid arthritis and interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Rituximab improves interstitial lung disease in rheumatoid arthritis patients
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
Infliximab treatment in patients with interstitial lung disease and rheumatoid arthritis
Source: Eur Respir J 2002; 20: Suppl. 38, 587s
Year: 2002
Methotrexate and rheumatoid arthritis associated interstitial lung disease
Source: Eur Respir J, 57 (2) 2000337; 10.1183/13993003.00337-2020
Year: 2021
RA autoantibodies as predictors of rheumatoid arthritis in non-cystic fibrosis bronchiectasis patients
Source: Eur Respir J 2014; 44: 1082-1085
Year: 2014
Pulmonary disease associated with rheumatoid arthritis
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
Pulmonary involvement in rheumatoid arthritis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008
Pulmonary involvement in rheumatoid arthritis
Source: Eur Respir Monogr 2019; 86: 44-67
Year: 2019
Pleural effusion as a manifestation of rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 612s
Year: 2006
Multiple pulmonary nodules in a male with psoriatic arthritis
Source: Eur Respir Rev 2009; 19: 164-165
Year: 2010
Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis
Source: Eur Respir J 2004; 24 : 708
Year: 2004
Pulmonary abnormalities in newly diagnosed rheumatoid arthritis
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Infliximab therapy in interstitial lung disease associated with rheumatoid arthritis
Source: Annual Congress 2004 - Fibrosing lung diseases
Year: 2004
The prognostic factors of cases with pulmonary involvement of rheumatoid arthritis at first discharge
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
A prognostic staging system for rheumatoid arthritis-associated interstitial lung disease
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept